Tissue Regenix Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.08	1.87	4.65	5.95	7.71	12.97
Cash & Short-Term Investments	1.08	1.87	4.65	5.95	7.71	12.97
Cash Growth	-68.94%	-59.78%	-21.84%	-22.83%	-40.55%	311.41%
Accounts Receivable	4.12	3.65	3.03	4.2	2.95	2.42
Other Receivables	0.13	0.44	0.48	0.44	0.65	1.25
Receivables	4.25	4.09	3.51	4.64	3.6	3.67
Inventory	16.7	14.01	10.36	10.88	9.72	9.6
Prepaid Expenses	-	0.67	0.58	0.57	1.04	1.04
Other Current Assets	0.77	0.63	-	-	-	-
Total Current Assets	22.79	21.27	19.09	22.04	22.06	27.28
Property, Plant & Equipment	8.09	8.31	9.02	8.94	9.1	7.75
Goodwill	-	11.59	11.59	11.59	11.59	11.59
Other Intangible Assets	16.31	1.53	1.62	2.07	2.69	3.42
Long-Term Deferred Charges	-	2.66	1.93	1.4	0.79	0.29
Total Assets	47.19	45.35	43.24	46.04	46.22	50.33
Accounts Payable	6.85	2.71	1.21	1.08	2.57	1.32
Accrued Expenses	-	2.11	2.54	4.4	1.62	2.57
Current Portion of Long-Term Debt	0.57	0.61	0.64	1	-	-
Current Portion of Leases	-	-	-	0.13	0.12	0.35
Current Income Taxes Payable	0.26	0.64	0.35	0.04	0.05	0.19
Other Current Liabilities	0.24	0.09	-	-	-	-
Total Current Liabilities	7.91	6.16	4.74	6.64	4.36	4.43
Long-Term Debt	10.43	9.86	8.75	5.26	4.47	3.79
Long-Term Leases	-	-	-	3.22	3.36	3.08
Long-Term Deferred Tax Liabilities	0.22	0.28	0.4	0.52	0.64	0.76
Total Liabilities	18.56	16.29	13.89	15.64	12.83	12.06
Common Stock	0.09	0.09	0.09	9.17	9.16	9.16
Additional Paid-In Capital	134.36	134.36	134.25	134.18	134.17	134.17
Retained Earnings	-125.03	-124.1	-123.76	-122.13	-120.43	-115.64
Treasury Stock	-1.26	-1.26	-1.26	-1.26	-1.26	-1.26
Comprehensive Income & Other	21.2	20.72	20.83	11.29	12.69	12.59
Total Common Equity	29.37	29.82	30.15	31.25	34.34	39.03
Minority Interest	-0.74	-0.76	-0.8	-0.85	-0.95	-0.76
Shareholders' Equity	28.62	29.06	29.36	30.4	33.39	38.27
Total Liabilities & Equity	47.19	45.35	43.24	46.04	46.22	50.33
Total Debt	11	10.47	9.4	9.61	7.95	7.22
Net Cash (Debt)	-9.92	-8.6	-4.75	-3.66	-0.24	5.75
Net Cash Growth	-	-	-	-	-	4517.86%
Net Cash Per Share	-0.14	-0.12	-0.07	-0.05	-0.00	0.13
Filing Date Shares Outstanding	71.23	71.23	70.41	70.2	70.17	70.17
Total Common Shares Outstanding	71.23	71.23	70.41	70.2	70.17	70.17
Working Capital	14.88	15.12	14.36	15.39	17.7	22.85
Book Value Per Share	0.41	0.42	0.43	0.45	0.49	0.56
Tangible Book Value	13.06	16.71	16.94	17.59	20.07	24.02
Tangible Book Value Per Share	0.18	0.23	0.24	0.25	0.29	0.34
Land	-	8.5	5.11	5.09	5.02	4.02
Machinery	-	4.81	5.57	5.05	5.06	4.65

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.